OneSource Pharma Partners Formycon AG for Biosimilar Manufacturing

OneSource Specialty Pharma Limited and Formycon AG have announced a strategic manufacturing partnership for biosimilars. Under this agreement, OneSource will act as a key manufacturing partner for Formycon, providing integrated Drug Substance (DS) and Drug Product (DP) manufacturing services from its facility in Bangalore. This collaboration aims to leverage Formycon's expertise in biosimilar development with OneSource's end-to-end biologics manufacturing capabilities to enhance global access to biosimilars. The partnership underscores a shared commitment to reliable, high-quality, and scalable manufacturing, with OneSource positioned to offer a sustainable and cost-effective model. Formycon brings a strong biosimilar portfolio and pipeline, while OneSource offers a comprehensive biologics platform and regulatory approvals from major authorities like the US FDA and EMA.